Published by Adis, 2014
ISBN 10: 3319030582 ISBN 13: 9783319030586
Seller: Lucky's Textbooks, Dallas, TX, U.S.A.
Condition: NEW.
Published by Adis, 2014
ISBN 10: 3319030582 ISBN 13: 9783319030586
Seller: GreatBookPrices, Columbia, MD, U.S.A.
Condition: NEW.
Published by Adis, 2014
ISBN 10: 3319030582 ISBN 13: 9783319030586
Seller: GreatBookPrices, Columbia, MD, U.S.A.
Condition: USED_ASNEW. Unread book in perfect condition.
Published by ADIS, 2014
ISBN 10: 3319030582 ISBN 13: 9783319030586
Seller: Ria Christie Collections, Uxbridge, United Kingdom
Condition: NEW. PRINT ON DEMAND Book; New; Fast Shipping from the UK. No. book.
Published by Adis, 2014
ISBN 10: 3319030582 ISBN 13: 9783319030586
Seller: booksXpress, Bayonne, NJ, U.S.A.
Soft Cover. Condition: NEW.
Published by ADIS 2014-10, 2014
ISBN 10: 3319030582 ISBN 13: 9783319030586
Seller: Chiron Media, Wallingford, United Kingdom
PF. Condition: NEW.
Published by Springer International Publishing Okt 2014, 2014
ISBN 10: 3319030582 ISBN 13: 9783319030586
Seller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germany
Taschenbuch. Condition: NEW. This item is printed on demand - it takes 3-4 days longer - Neuware -Guide to Targeted Therapies: EGFR Mutations in NSCLC is a speedy and up-to-date review, which discusses EGFR mutations, testing methods and technology, current and emerging therapies, and resources that clinicians can provide to their patients. Busy healthcare professionals who want a quick review of EGFR gene mutations as well as a summary of current therapies will benefit from this succinct guide. 80 pp. Englisch.
Published by Springer Verlag, 2014
ISBN 10: 3319030582 ISBN 13: 9783319030586
Seller: Revaluation Books, Exeter, United Kingdom
Paperback. Condition: NEW. 1st edition. 67 pages. 7.75x5.00x0.25 inches. In Stock.
Published by Adis, 2014
ISBN 10: 3319030582 ISBN 13: 9783319030586
Seller: GreatBookPricesUK, Castle Donington, DERBY, United Kingdom
Condition: NEW.
Published by Adis, 2014
ISBN 10: 3319030582 ISBN 13: 9783319030586
Seller: GreatBookPricesUK, Castle Donington, DERBY, United Kingdom
Condition: USED_ASNEW. Unread book in perfect condition.
Published by Springer International Publishing, Springer International Publishing, 2014
ISBN 10: 3319030582 ISBN 13: 9783319030586
Seller: AHA-BUCH GmbH, Einbeck, Germany
Taschenbuch. Condition: NEW. Druck auf Anfrage Neuware - Printed after ordering - Guide to Targeted Therapies: EGFR Mutations in NSCLC is a speedy and up-to-date review, which discusses EGFR mutations, testing methods and technology, current and emerging therapies, and resources that clinicians can provide to their patients. Busy healthcare professionals who want a quick review of EGFR gene mutations as well as a summary of current therapies will benefit from this succinct guide.
Published by Springer International Publishing Okt 2015, 2015
ISBN 10: 3319207407 ISBN 13: 9783319207407
Seller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germany
Taschenbuch. Condition: NEW. This item is printed on demand - it takes 3-4 days longer - Neuware -This text is a concise and up-to-date review, which discusses the background, development and mechanisms of resistance, testing methods and technology, current and emerging therapies and resources that clinicians can provide to their patients. Busy healthcare professionals who want a quick review of treatment resistance in lung cancer as well as a summary of current therapies will benefit from this succinct guide. 76 pp. Englisch.
Published by Springer International Publishing AG, 2014
ISBN 10: 3319030582 ISBN 13: 9783319030586
Seller: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Ireland
Condition: NEW. Guide to Targeted Therapies: EGFR mutations in NSCLC Num Pages: 67 pages, 16 colour illustrations, biography. BIC Classification: MJCL; MJL. Category: (P) Professional & Vocational. Dimension: 130 x 204 x 4. Weight in Grams: 102. . 2014. 2014th Edition. Paperback. . . . .
Published by Springer International Publishing, 2015
ISBN 10: 3319207407 ISBN 13: 9783319207407
Seller: AHA-BUCH GmbH, Einbeck, Germany
Taschenbuch. Condition: NEW. Druck auf Anfrage Neuware - Printed after ordering - This text is a concise and up-to-date review, which discusses the background, development and mechanisms of resistance, testing methods and technology, current and emerging therapies and resources that clinicians can provide to their patients. Busy healthcare professionals who want a quick review of treatment resistance in lung cancer as well as a summary of current therapies will benefit from this succinct guide.
Published by Springer International Publishing, 2014
ISBN 10: 3319030582 ISBN 13: 9783319030586
Seller: moluna, Greven, Germany
Condition: NEW. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. A concise, practical handbook on EGFR mutations in NSCLC that provides oncologists and other healthcare providers with an up-to-date review of the background and advances in the field Reviews the current treatment recommendations for EGFR mutation.
Published by Springer International Publishing AG, 2014
ISBN 10: 3319030582 ISBN 13: 9783319030586
Seller: Kennys Bookstore, Olney, MD, U.S.A.
Condition: NEW. Guide to Targeted Therapies: EGFR mutations in NSCLC Num Pages: 67 pages, 16 colour illustrations, biography. BIC Classification: MJCL; MJL. Category: (P) Professional & Vocational. Dimension: 130 x 204 x 4. Weight in Grams: 102. . 2014. 2014th Edition. Paperback. . . . . Books ship from the US and Ireland.
Published by Adis, 2015
ISBN 10: 3319207407 ISBN 13: 9783319207407
Seller: Revaluation Books, Exeter, United Kingdom
Paperback. Condition: NEW. 67 pages. 7.91x5.00x0.18 inches. In Stock.
Published by Springer International Publishing, 2015
ISBN 10: 3319207407 ISBN 13: 9783319207407
Seller: moluna, Greven, Germany
Kartoniert / Broschiert. Condition: NEW. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. A concise, practical handbook on treatment resistance in lung cancerProvides oncologists and other healthcare workers involved in the diagnosis, treatment and management of patients with an up-to-date review of the background and advances in the f.